中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 42 Issue 8
Aug.  2026
Turn off MathJax
Article Contents

Difficulties in the diagnosis and treatment of distal cholangiocarcinoma: A case report

DOI: 10.12449/JCH260826
Research funding:

Meizhou City Medical and Health Science and Technology Research Projects (2024-B-9)

More Information
  • Corresponding author: Zeng Dehui, 13727624698@163.com (ORCID: 0009-0001-9311-5346)
  • Received Date: 2025-10-02
  • Accepted Date: 2025-12-30
  • Published Date: 2026-08-25
  • Distal cholangiocarcinoma (dCCA) often has subtle symptoms in its early stage, and the optimal surgical timing is often missed at the time of diagnosis. This article reports a patient with dCCA who attended the hospital due to obstructive jaundice. Although the patient had a history of liver fluke infection and positive serological results, persistent stricture of the common bile duct remained unrelieved after adequate drainage and infection control. Due to the longitudinal growth pattern of the tumor, multiple endoscopic biopsies yielded false-negative results. Multidisciplinary consultation recommended a 1-month follow-up, but the patient failed to return to hospital for review and was found to have liver metastasis (stage Ⅳ) at the time of confirmed diagnosis, and thus the patient missed the opportunity for radical surgery. This article summarizes the common pitfalls and lessons in the early diagnosis of dCCA and proposes that for highly suspected cases in clinical practice, it is crucial to conduct multidisciplinary diagnosis and treatment, integrate dynamic imaging and tumor marker monitoring, and implement proactive structured evaluations, so as to avoid diagnostic and therapeutic delays and ultimately improve the prognosis of patients.

     

  • loading
  • [1]
    Valle J W, Kelley R K, Nervi B, et al. Biliary tract cancer[J]. Lancet, 2021, 397( 10272): 428- 444. DOI: 10.1016/S0140-6736(21)00153-7.
    [2]
    European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma[J]. J Hepatol, 2025, 83( 1): 211- 238. DOI: 10.1016/j.jhep.2025.03.007.
    [3]
    Qurashi M, Vithayathil M, Khan S A. Epidemiology of cholangiocarcinoma[J]. Eur J Surg Oncol, 2025, 51( 2): 107064. DOI: 10.1016/j.ejso.2023.107064.
    [4]
    Razumilava N, Gores G J. Cholangiocarcinoma[J]. Lancet, 2014, 383( 9935): 2168- 2179. DOI: 10.1016/S0140-6736(13)61903-0.
    [5]
    Liu Yao, Liu Lianxin. New advances in diagnosis and treatment of advanced cholangiocarcinoma[J]. Chin J Dig Surg, 2025, 24( 7): 855- 861. DOI: 10.3760/cma.j.cn115610-20250606-00261.

    刘尧, 刘连新. 晚期胆管癌诊断与治疗新进展[J]. 中华消化外科杂志, 2025, 24( 7): 855- 861. DOI: 10.3760/cma.j.cn115610-20250606-00261.
    [6]
    Tjaden C, Hinz U, Klaiber U, et al. Distal bile duct cancer: Radical(R0> 1 mm) resection achieves favorable survival[J]. Ann Surg, 2023, 277( 1): e112- e118. DOI: 10.1097/SLA.0000000000005012.
    [7]
    Chen Shanshan, Li Wei. Research advances in non-surgical treatment of distal cholangiocarcinoma[J]. J Clin Hepatol, 2021, 37( 7): 1729- 1732. DOI: 10.3969/j.issn.1001-5256.2021.07.053.

    陈姗姗, 李威. 远端胆管癌非手术治疗的研究进展[J]. 临床肝胆病杂志, 2021, 37( 7): 1729- 1732. DOI: 10.3969/j.issn.1001-5256.2021.07.053.
    [8]
    Guedj N. Pathology of cholangiocarcinomas[J]. Curr Oncol, 2022, 30( 1): 370- 380. DOI: 10.3390/curroncol30010030.
    [9]
    Junquera Alonso E, Vargas González C, Terroba Alonso M, et al. Diagnosis of biliary papillomatosis with a Spyglass® cholangioscope[J]. Rev Esp Enferm Dig, 2022, 114( 7): 439- 440. DOI: 10.17235/reed.2022.8612/2022.
    [10]
    Rushbrook S M, Kendall T J, Zen Y, et al. British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma[J]. Gut, 2023, 73( 1): 16- 46. DOI: 10.1136/gutjnl-2023-330029.
    [11]
    Elvevi A, Laffusa A, Scaravaglio M, et al. Clinical treatment of cholangiocarcinoma: An updated comprehensive review[J]. Ann Hepatol, 2022, 27( 5): 100737. DOI: 10.1016/j.aohep.2022.100737.
    [12]
    Sugita H, Nakanuma S, Gabata R, et al. Clinicopathological features of cholangiolocarcinoma and impact of tumor heterogeneity on prognosis: A single institution retrospective study[J]. Oncol Lett, 2024, 27( 5): 213. DOI: 10.3892/ol.2024.14346.
    [13]
    Rizzo A, Brandi G. Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer[J]. Expert Rev Gastroenterol Hepatol, 2021, 15( 5): 547- 554. DOI: 10.1080/17474124.2021.1890031.
    [14]
    Lamarca A, Barriuso J, Chander A, et al. 18F-fluorodeoxyglucose positron emission tomography(18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis[J]. J Hepatol, 2019, 71( 1): 115- 129. DOI: 10.1016/j.jhep.2019.01.038.
    [15]
    van Roessel S, Soer E C, Daamen L A, et al. Preoperative misdiagnosis of pancreatic and periampullary cancer in patients undergoing pancreatoduodenectomy: A multicentre retrospective cohort study[J]. Eur J Surg Oncol, 2021, 47( 10): 2525- 2532. DOI: 10.1016/j.ejso.2021.03.228.
    [16]
    Tang Bofu, Yuanyuan Nian, Dang Tong. Advances of confocal laser endomicroscope in digestive diseases[J]. Chin J Dig Endosc, 2022, 39( 2): 164- 168. DOI: 10.3760/cma.j.cn321463-20210301-00057.

    汤泊夫, 年媛媛, 党彤. 激光共聚焦显微内镜在消化系统疾病中的应用进展[J]. 中华消化内镜杂志, 2022, 39( 2): 164- 168. DOI: 10.3760/cma.j.cn321463-20210301-00057.
    [17]
    Kotsifa E, Saffioti F, Mavroeidis V K. Cholangiocarcinoma: The era of liquid biopsy[J]. World J Gastroenterol, 2025, 31( 11): 104170. DOI: 10.3748/wjg.v31.i11.104170.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)

    Article Metrics

    Article views (9) PDF downloads(0) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return